InvestorsHub Logo
Followers 4
Posts 108
Boards Moderated 0
Alias Born 01/03/2017

Re: GregLechuga post# 26676

Wednesday, 02/08/2017 12:53:58 AM

Wednesday, February 08, 2017 12:53:58 AM

Post# of 94862
"To clinically prove these antidiabetic benefits in humans, Protext Pharma will undertake with Phytofare® catechins, delivered in a capsule, an independent double blind clinical study in the second quarter 2017; with the objective to commercialize an affordable solution in what is a multibillion dollar global market opportunity for the prevention and containment of metabolic syndrome causes.